Zhejiang University Reports Findings in Multiple Myeloma (Clinical outcomes of pomalidomide-based and daratumumab-based therapies in patients with relapsed/refractory multiple myeloma: A real-world cohort study in China)

Prensa/medios de comunicación: !!!Research

Períodomay. 22 2024

Cobertura de los medios

1

Cobertura de los medios

  • NombreZhejiang University Reports Findings in Multiple Myeloma (Clinical outcomes of pomalidomide-based and daratumumab-based therapies in patients with relapsed/refractory multiple myeloma: A real-world cohort study in China)
    Nombre/canal del medio de comunicaciónDaily China News
    País/TerritorioEstados Unidos
    Fecha22/5/24
    PersonasYang Yang